C-Rad AB (publ)

OM:CRAD B Stock Report

Market Cap: SEK 1.1b

C-Rad Past Earnings Performance

Past criteria checks 2/6

C-Rad has been growing earnings at an average annual rate of 42.8%, while the Medical Equipment industry saw earnings growing at 9.6% annually. Revenues have been growing at an average rate of 20% per year. C-Rad's return on equity is 9.8%, and it has net margins of 6.9%.

Key information

42.77%

Earnings growth rate

43.14%

EPS growth rate

Medical Equipment Industry Growth6.16%
Revenue growth rate20.01%
Return on equity9.80%
Net Margin6.86%
Next Earnings Update18 Jul 2025

Recent past performance updates

C-Rad's (STO:CRAD B) Earnings Are Weaker Than They Seem

Feb 15
C-Rad's (STO:CRAD B) Earnings Are Weaker Than They Seem

Recent updates

Results: C-Rad AB (publ) Delivered A Surprise Loss And Now Analysts Have New Forecasts

May 09
Results: C-Rad AB (publ) Delivered A Surprise Loss And Now Analysts Have New Forecasts

Investors Continue Waiting On Sidelines For C-Rad AB (publ) (STO:CRAD B)

Apr 15
Investors Continue Waiting On Sidelines For C-Rad AB (publ) (STO:CRAD B)

C-Rad's (STO:CRAD B) Earnings Are Weaker Than They Seem

Feb 15
C-Rad's (STO:CRAD B) Earnings Are Weaker Than They Seem

Earnings Miss: C-Rad AB (publ) Missed EPS By 9.8% And Analysts Are Revising Their Forecasts

Feb 12
Earnings Miss: C-Rad AB (publ) Missed EPS By 9.8% And Analysts Are Revising Their Forecasts
author-image

Global Expansion And SGRT Demand Will Drive Future Success

Strategic global expansion, particularly in APAC, and long-term contracts in advanced markets support revenue growth and market share increase.

Sentiment Still Eluding C-Rad AB (publ) (STO:CRAD B)

Oct 24
Sentiment Still Eluding C-Rad AB (publ) (STO:CRAD B)

Market Participants Recognise C-Rad AB (publ)'s (STO:CRAD B) Earnings Pushing Shares 29% Higher

Jun 02
Market Participants Recognise C-Rad AB (publ)'s (STO:CRAD B) Earnings Pushing Shares 29% Higher

Returns On Capital Are A Standout For C-Rad (STO:CRAD B)

Mar 01
Returns On Capital Are A Standout For C-Rad (STO:CRAD B)

C-Rad's (STO:CRAD B) Earnings Are Weaker Than They Seem

Feb 15
C-Rad's (STO:CRAD B) Earnings Are Weaker Than They Seem

Do C-Rad's (STO:CRAD B) Earnings Warrant Your Attention?

Feb 03
Do C-Rad's (STO:CRAD B) Earnings Warrant Your Attention?

C-Rad AB (publ)'s (STO:CRAD B) Popularity With Investors Is Clear

Jan 19
C-Rad AB (publ)'s (STO:CRAD B) Popularity With Investors Is Clear

Is Now The Time To Look At Buying C-Rad AB (publ) (STO:CRAD B)?

Oct 28
Is Now The Time To Look At Buying C-Rad AB (publ) (STO:CRAD B)?

Returns Are Gaining Momentum At C-Rad (STO:CRAD B)

Aug 16
Returns Are Gaining Momentum At C-Rad (STO:CRAD B)

Are Investors Undervaluing C-Rad AB (publ) (STO:CRAD B) By 45%?

Dec 14
Are Investors Undervaluing C-Rad AB (publ) (STO:CRAD B) By 45%?

Is Now An Opportune Moment To Examine C-Rad AB (publ) (STO:CRAD B)?

Jul 20
Is Now An Opportune Moment To Examine C-Rad AB (publ) (STO:CRAD B)?

Returns Are Gaining Momentum At C-Rad (STO:CRAD B)

May 07
Returns Are Gaining Momentum At C-Rad (STO:CRAD B)

Earnings Miss: C-Rad AB (publ) Missed EPS By 5.5% And Analysts Are Revising Their Forecasts

Jan 30
Earnings Miss: C-Rad AB (publ) Missed EPS By 5.5% And Analysts Are Revising Their Forecasts

C-Rad (STO:CRAD B) Shareholders Will Want The ROCE Trajectory To Continue

Jul 03
C-Rad (STO:CRAD B) Shareholders Will Want The ROCE Trajectory To Continue

Will the Promising Trends At C-Rad (STO:CRAD B) Continue?

Mar 05
Will the Promising Trends At C-Rad (STO:CRAD B) Continue?

Are C-Rad's (STO:CRAD B) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Feb 07
Are C-Rad's (STO:CRAD B) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Revenue & Expenses Breakdown

How C-Rad makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

OM:CRAD B Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 25470322350
31 Dec 24469562430
30 Sep 24486582590
30 Jun 24497542570
31 Mar 24458482420
31 Dec 23425362290
30 Sep 23385242160
30 Jun 23357202050
31 Mar 23329121950
31 Dec 2230171790
30 Sep 22280141540
30 Jun 22260121430
31 Mar 22257211310
31 Dec 21261251240
30 Sep 21258261200
30 Jun 21247251140
31 Mar 21230171100
31 Dec 20222141090
30 Sep 20198-111100
30 Jun 20201-161150
31 Mar 20210-141200
31 Dec 19205-141170
30 Sep 19212231140
30 Jun 19203241110
31 Mar 19204271060
31 Dec 18190211050
30 Sep 18174-21010
30 Jun 18161-4940
31 Mar 18141-10910
31 Dec 17133-11880
30 Sep 17118-16840
30 Jun 17108-23830
31 Mar 1790-28800
31 Dec 1683-31750
30 Sep 1674-33710
30 Jun 1670-32670
31 Mar 1673-27620
31 Dec 1573-21580
30 Sep 1573-20570
30 Jun 1566-16520
31 Mar 1562-8500
31 Dec 1457-7470
30 Sep 1456-5450
30 Jun 1459-4440

Quality Earnings: CRAD B has high quality earnings.

Growing Profit Margin: CRAD B's current net profit margins (6.9%) are lower than last year (10.6%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: CRAD B has become profitable over the past 5 years, growing earnings by 42.8% per year.

Accelerating Growth: CRAD B's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: CRAD B had negative earnings growth (-33.4%) over the past year, making it difficult to compare to the Medical Equipment industry average (-0.3%).

Return on Equity

High ROE: CRAD B's Return on Equity (9.8%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/27 09:39
End of Day Share Price 2025/05/27 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

C-Rad AB (publ) is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Victor ForssellABG Sundal Collier Sponsored
Christian LeePareto Securities